ACOG Calls for Routine Cannabis Screening as Use Reaches 7% in Pregnancy – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Cannabis is linked to higher rates of preterm birth, low birth weight, and neurodevelopmental issues in babies. Many still think it’s safe—it’s not risk-free!
The American College of Obstetricians and Gynecologists (ACOG) now calls for universal screening of all reproductive-aged individuals for cannabis use during prepregnancy, pregnancy, and lactation. This shift responds to rising cannabis use—now up to 7% in pregnancy—amid nationwide legalization. Research confirms increased risks of preterm birth, low birth weight, and neurodevelopmental impacts in exposed infants. Clinicians are urged to use interviews and validated tools, avoiding biologic drug tests that can result in inequitable care. ACOG highlights the need for evidence-based counseling and risk-reduction strategies personalized to each patient.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 15, 2026, 18:18A PCOS Diagnosis Can Stay in the Background of Every Fertility Conversation – Banker IVF and Women’s Hospital
-
Sep 15, 2026, 18:15The Difference Between Ovulation Induction and Ovarian Stimulation – Fertility Plus
-
Sep 15, 2026, 18:13Ritu Anand: What Would I Tell an IVF Couple in the 1980s?
-
Sep 15, 2026, 18:11STP Curriculum Feedback Survey – The Association of Reproductive and Clinical Scientists
-
Sep 15, 2026, 18:09Khushi Mishra: ICSI – Where Precision Meets the Possibility of Life
-
Sep 15, 2026, 18:06Khalil Faaed: The Future of niPGT-A Is Not Just Non-Invasive…
-
Sep 15, 2026, 18:04Anuradha Housnur: ICSI Is Not About Injecting the Sperm…
-
Sep 15, 2026, 18:02Snehal Kaware: Can an Oocyte With a Vacuole Still Fertilize?
-
Sep 15, 2026, 17:59Kanishka Gaur: Amenorrhea Is a Symptom, Not a Diagnosis